The Federal Circuit upheld a tribunal decision invalidating a Merck & Co. unit’s patent of a multiple sclerosis drug, reinforcing the court’s precedential interpretation of key language in the Patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback